Scenes from TTLC 2023
Revisit all your favorite moments from #TTLC23 in our photo gallery.
About the authors
Related Articles
-
New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind
-
ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology
-
Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients
-
Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations